Litcius/Paper detail

Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy

Amandeep Arora, Ahmed S. Zugail, Felipe Guimarães Pugliesi, Xavier Cathelineau, Petr Macek, Y. Barbé, R. Jeffrey Karnes, Mohamed E. Ahmed, Ettore Di Trapani, Francesco Soria, Mario Álvarez‐Maestro, Francesco Montorsi, Alberto Briganti, Andrea Necchi, Benjamin Pradère, David D‘Andrea, Wojciech Krajewski, M. Roumiguié, Anne Sophie Bajeot, Rodolfo Hurle, Roberto Contieri, Roberto Carando, Jeremy Yuen‐Chun Teoh, Morgan Rouprêt, Daniel Benamran, Guillaume Ploussard, Maria Carmen Mir, Rafael Sanchez‐Salas, Marco Moschini

2022World Journal of Urology15 citationsDOI

Topics & Concepts

MedicineCystectomyBladder cancerLogistic regressionNephrologyIncidence (geometry)Internal medicineChemotherapyPerioperativeRetrospective cohort studyUrologySurgeryCancerOpticsPhysicsBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrinary Tract Infections Management
Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy | Litcius